Trial | NCT01610778  Report issue

Title

Effects of 5-Aminolevulinic Acid on Glucose Metabolism
A Randomized, Double-blind, Cross-over Study to Assess Efficacy of 5-Aminolevulinic Acid in Type 2 Diabetic Patients on Medication.

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    35
This study is designed to evaluate efficacy of 5-aminolevulinic acid in subjects with type 2 diabetes on medication.
Study Started
May 31
2012
Primary Completion
Sep 30
2013
Study Completion
Sep 30
2013
Last Update
Dec 19
2013
Estimate

Dietary Supplement Placebo

Dietary Supplement 5-aminolevulinic acid phosphate

Placebo Placebo Comparator

Supplement Experimental

Criteria 

Inclusion Criteria:

Type 2 diabetic patients on medication
HbA1c ≤ 9.0% (as JDS values, which is equivalent to HbA1c ≤ 9.4% as NGSP values)
On stable treatment of diabetes for at least the last 3 months
With permission to attend the clinical trial from the primary doctor

Exclusion Criteria:

On insulin therapy
BMI ≤ 18 kg/m2 or ≥ 30 kg/m2
History of porphyria, hemochromatosis, or viral hepatitis
Pregnant or nursing a child
Heart disease
Renal or hepatic dysfunction
Participation in any clinical trial within 90 days of the commencement of the trial
No Results Posted